Navigation Links
Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
Date:3/17/2011

ded period of time continued to show undetectable virus levels six months after they completed SOC. SOC treatment alone usually results in about 40-50% of patients reaching undetectable virus levels after six months of treatment.

About Inovio Pharmaceuticals, Inc. Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. These SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses. Inovio's clinical programs include three separate programs in Phase II clinical studies, including VGX-3100 for treating cervical dysplasia and cancer. Other Inovio clinical programs include those for avian flu (preventive) and HIV vaccines (both preventive and therapeutic). Inovio is developing universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may n
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
2. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
3. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
4. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
5. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
6. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
7. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
8. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
9. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
10. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
11. Akrimax Pharmaceuticals, LLC, Introduces NitroMist® (Nitroglycerin Lingual Aerosol) 400mcg/Spray
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... , April 28, 2015 ... Berlin and the Charité creates ... as a central research location   ... technical and medical information products and services, has announced ... the Humboldt University (Humboldt-Universität), the Free University of ...
(Date:4/28/2015)... WILMINGTON, N.C. , April 28, 2015 ... of the Year (CRoY) winners in the UK, joining the ... earned the Gold Pharma in the CTA category and ... Both Chiltern Source professionals are working with Novartis. ... this recognition as top performers in the industry," commented ...
(Date:4/28/2015)...   GenSpera, Inc. (OTCQB: GNSZ) announced ... has issued U.S. Patent No. 8,957,016. This patent ... for the company,s prodrugs designed to be activated ... GenSpera is developing a series of prodrugs that ... from the poisonous plant, Thapsia garganica . The ...
Breaking Medicine Technology:Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 2Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 3Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 2Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 3GenSpera Granted New Patent for Prodrugs Activated by Prostate Specific Antigen 2
(Date:4/28/2015)... 2015 Wimbledon Health Partners, the ... electrocardiogram, echocardiogram, and NCV testing, has expanded their ... help podiatrists diagnose peripheral arterial disease (PAD). ... without the aid of vascular testing,” said ... at Wimbledon Health Partners. “Diminished peripheral pulses, atrophic ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Once considered an ... Lights have taken the industry by storm with perfectly tailored ... use unit. , More than half of every ... KIND LED , proving the stigma is gone and LED ... overwhelming positive response from customers and their first hand experience ...
(Date:4/28/2015)... “ Gwee ” was featured on ... features the latest and coolest technology products available to ... for NewsWatch, conducted the review and shared with viewers ... As much as everyone loves their tablets, it’s annoying ... looking at them, it's even more annoying trying to ...
(Date:4/28/2015)... The Awareness Counselor team has introduced a new ... According to Awareness Counselor, there are ramifications of judging. Judging ... to an individual who self-judges. This new concept is now ... or one one one talk. , The premise of this ... that every being on earth is here for a purpose ...
(Date:4/28/2015)... Henderson, NV (PRWEB) April 28, 2015 ... University's Center for Ethics (June 27, 2014), prescription ... the world. Medical Science is becoming increasingly aware of ... on the market, such as chemotherapy drugs to treat ... bacteria that are quickly evolving to become increasingly resistant ...
Breaking Medicine News(10 mins):Health News:Podiatrists Affiliate with Wimbledon Health Partners to Diagnose Peripheral Arterial Disease 2Health News:SuperCloset Reports Surge in KIND LED Grow Light Sales, Saving Indoor Growing Enthusiasts up to 40% on their Power Usage. 2Health News:The Most Innovative iPad Case was Featured on NewsWatch Television 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 3Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 2Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 3Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 4
... Partners is being recognized as one of the top performing California ... year. HealthCare Partners is one of only four California Physicians groups ... , ... (PRWEB) November 11, 2008 -- This is the ...
... Awareness Month--The Apo E Gene Diet--A Solution for ... Other Chronic Illnesses. ,THE APO E GENE DIET ... and Weight Loss" category of National Best Books ... E Gene Diet presents an integrative medicine solution ...
... The 2008 Frost &,Sullivan European Health Ingredient ... in recognition of its pioneering efforts in developing ... "Rather than cure, current medical treatments for ... pain," notes Frost & Sullivan,Research Analyst Kaushik Ghosh. ...
... Nov. 10 KV Pharmaceutical Company,(NYSE: KVa/KVb) announced today ... the Company will be delayed in the filing of,its ... The Company expects to,file a Form 12b-25 Notice of ... November 12, 2008., About KV Pharmaceutical Company, ...
... announced,today that the Company Chief Executive Officer, Steve ... pipeline, at the Rodman &,Renshaw,s 10th Annual Healthcare ... EST at the New York Palace Hotel, 455 ... is a private drug development Company,founded in 1996 ...
... HARRISBURG, Pa., Nov. 10 State agriculture,and health officials ... about important food safety issues made four stops in,northeastern ... Health Secretary Michael,Huff visited the area as part of ... which is a comprehensive plan to address,food safety and ...
Cached Medicine News:Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 2Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 3Health News:The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time 2Health News:The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time 3Health News:The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time 4Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 2Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 3Health News:KV Pharmaceutical to File Form 12b-25 on November 12, 2008 2Health News:KV Pharmaceutical to File Form 12b-25 on November 12, 2008 3Health News:KV Pharmaceutical to File Form 12b-25 on November 12, 2008 4Health News:Agriculture, Health Officials Address Food Safety Concerns During Northeastern PA Tour 2
Compact benchtop clinical chemistry system...
... The VITROS 350 Chemistry System offers easy ... as a primary, STAT, or back-up to the ... System will get the job done right the ... that VITROS Systems are efficient, dependable, and easy-to-use. ...
Meet Galileo, the best reason to move to automation; the best way to upgrade your capabilities....
... gel sample slots 0.4 mm or larger ... flexible, autoclavable, precision tapered polycarbonate tips (T ... contact sample. Includes 6 tips (0.34 ... plastic spacer. Comp ...
Medicine Products: